Healthcare provider profile · identity verified

Lawrence E Udom, MD, MPH, FAAFP

Family Practice · DAYTON, OH · NPI 1659572527

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	484	150
Amlodipine Besylate	Amlodipine Besylate	458	149
Gabapentin	Gabapentin	330	88
Omeprazole	Omeprazole	240	80
Levothyroxine Sodium	Levothyroxine Sodium	214	50
Albuterol Sulfate Hfa	Albuterol Sulfate	204	70
Olmesartan Medoxomil	Olmesartan Medoxomil	192	60
Furosemide	Furosemide	160	45
Pantoprazole Sodium	Pantoprazole Sodium	157	47
Tamsulosin Hcl	Tamsulosin Hcl	151	53
Metoprolol Succinate	Metoprolol Succinate	149	46
Losartan Potassium	Losartan Potassium	138	39
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	135	38
Lisinopril	Lisinopril	130	40
Fluticasone Propionate	Fluticasone Propionate	127	56
Potassium Chloride	Potassium Chloride	123	26
Metformin Hcl	Metformin Hcl	121	39
Allopurinol	Allopurinol	114	38
Methocarbamol	Methocarbamol	107	49
Rosuvastatin Calcium	Rosuvastatin Calcium	107	38
Simvastatin	Simvastatin	104	27
Metformin Hcl Er	Metformin Hcl	88	28
Prednisone	Prednisone	80	57
Famotidine	Famotidine	79	30
Sertraline Hcl	Sertraline Hcl	79	26
Jardiance	Empagliflozin	74	24
Pravastatin Sodium	Pravastatin Sodium	73	28
Carvedilol	Carvedilol	71	27
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	71	23
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	20
Hydrochlorothiazide	Hydrochlorothiazide	68	27
Montelukast Sodium	Montelukast Sodium	66	23
Clopidogrel	Clopidogrel Bisulfate	64	21
Metoprolol Tartrate	Metoprolol Tartrate	58	18
Hydralazine Hcl	Hydralazine Hcl	57	18
Donepezil Hcl	Donepezil Hcl	54	15
Hydroxyzine Hcl	Hydroxyzine Hcl	54	20
Finasteride	Finasteride	53	20
Ozempic	Semaglutide	53	13
Pregabalin	Pregabalin	53	18
Buspirone Hcl	Buspirone Hcl	51	16
Glimepiride	Glimepiride	50	16
Mirtazapine	Mirtazapine	50	14
Trazodone Hcl	Trazodone Hcl	47	17
Alendronate Sodium	Alendronate Sodium	43	12
Breo Ellipta	Fluticasone/Vilanterol	43	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	42	14
Duloxetine Hcl	Duloxetine Hcl	40	11
Meloxicam	Meloxicam	39	26
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	12
Tresiba Flextouch U-100	Insulin Degludec	38	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	37	11
Doxazosin Mesylate	Doxazosin Mesylate	34	11
Januvia	Sitagliptin Phosphate	33	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	33	13
Farxiga	Dapagliflozin Propanediol	32	suppressed
Synthroid	Levothyroxine Sodium	32	12
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Eliquis	Apixaban	31	13
Amitriptyline Hcl	Amitriptyline Hcl	30	11
Trulicity	Dulaglutide	30	suppressed
Diclofenac Sodium	Diclofenac Sodium	29	12
Esomeprazole Magnesium	Esomeprazole Magnesium	29	11
Doxycycline Hyclate	Doxycycline Hyclate	28	28
Ezetimibe	Ezetimibe	28	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	11
Klor-Con M20	Potassium Chloride	26	suppressed
Myrbetriq	Mirabegron	25	suppressed
Calcitriol	Calcitriol	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Tramadol Hcl	Tramadol Hcl	23	19
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Amlodipine-Valsartan	Amlodipine Besylate/Valsartan	21	suppressed
Atenolol	Atenolol	21	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	21	suppressed
Doxepin Hcl	Doxepin Hcl	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Methylprednisolone	Methylprednisolone	20	20
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Glipizide	Glipizide	19	suppressed
Repatha Sureclick	Evolocumab	19	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	17
Warfarin Sodium	Warfarin Sodium	19	suppressed
Olmesartan-Amlodipine-Hctz	Olmesartan/Amlodipin/Hcthiazid	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Spiriva Respimat	Tiotropium Bromide	17	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	16	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Clonazepam	Clonazepam	14	11
Dulera	Mometasone/Formoterol	14	suppressed
Fluconazole	Fluconazole	14	12
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Ventolin Hfa	Albuterol Sulfate	14	suppressed
Xarelto	Rivaroxaban	14	suppressed
Atenolol-Chlorthalidone	Atenolol/Chlorthalidone	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Loperamide	Loperamide Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Nystatin	Nystatin	13	suppressed
Terazosin Hcl	Terazosin Hcl	13	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	12	suppressed
Ingrezza	Valbenazine Tosylate	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	11
Pioglitazone Hcl	Pioglitazone Hcl	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	12	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Bupropion Xl	Bupropion Hcl	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Telmisartan	Telmisartan	11	suppressed
Testosterone Cypionate	Testosterone Cypionate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error